We recently published a list of 10 Best Annual Dividend Stocks To Buy Now. In this article, we are going to take a look at ...

This week, Sanofi SNY and Roche RHHBY announced their fourth-quarter and full-year 2024 results. Novo Nordisk’s NVO novel ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating IBD. Nabaparna Bhattacharya Sarepta Therapeutics' Duchenne Gene Therapy ...

4 This announcement follows the assay's CE Mark approval in Ju Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today ... for all outstanding shares of common stock of Poseida Therapeutics, Inc ...

We believe that this was related to stock-outs of other products included in the market definition, primarily [indiscernible]. To account for this, the Q3 values were restated to improve accuracy.

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months.